Contemporary management of and outcomes from cardiac device related infections

Europace

Volumn 12, Issue 1, 2010, Pages 64-70

  Margey, Ronan ^a   McCann, Hugh ^a   Blake, Gavin ^a   Keelan, Edward ^a   Galvin, Joseph ^a   Lynch, Maureen ^a   Mahon, Niall ^a   Sugrue, Declan ^a   O'Neill, James ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Cardiac device infection; Cardiac device endocarditis; Endocarditis; Implantable cardioverter defibrillator infection; Pacemaker infection

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM; CEPHALOSPORIN; CORTICOSTEROID; ERYTHROMYCIN; NEOMYCIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL HEART PACEMAKER; BACTERIAL INFECTION; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE INFECTION; DIARRHEA; DRUG SAFETY; FEMALE; FEVER; FOLLOW UP; HUMAN; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; NEUTROPENIA; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REIMPLANTATION; RELAPSE; RETROSPECTIVE STUDY; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

ADULT; AGED, 80 AND OVER; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; FEMALE; HUMANS; IRELAND; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 73849120250     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup362     Document Type: Article

References (22)

1. Goldberger Z, Lampert R. Implantable cardioverter-defibrillator: expanding indications and technologies. JAMA 2006;295:809-818
2. Birnie D, Williams K, Mielniczuk L, Davis D, Lemery R, Green M et al. Reasons for escalating pacemaker implants. Am J Cardiol 2006;98:93-97
3. Chua JD, Juratli N, Longworth DL, Gordon SM, Wilkoff BL, Lee L. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Int Med 2000;133:604-608
4. Voight A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003 [letter]. JACC 2006;48:590-591
5. Cabell CH, Heidenreich PA, Moore CM, Stryjewski E, Corey RG, Fowler VG et al. Increasing rates of cardiac device infections among Medicare beneficiaries 1990-1999. Am Heart J 2004;147:582-586
6. Conklin EF, Giannelli S Jr, Nealon TF Jr. Four hundred consecutive patients with permanent transvenous pacemakers. J Thoracic Cardiovasc Surg 1975;69:1-7
7. Mela T, Mc Govern BA, Goran H, Vlahakes GJ, Torchiana DF, Ruskin J et al. Long term infection rates associated with the pectoral versus abdominal approach to cardioverter-defibrillator implants. Am J Cardiol 2001;88:750-753
8. Uslan DZ, Baddour LM. Cardiac device infections: getting to the heart of the matter. Curr Opin Infect Dis 2006;19:345-348
9. Cacoub P, Leprince P, Hounsfater P, Doroub R, Wecksler B, Bors V et al. Pacemaker infective endocarditis. Am J Cardiol 1998;82:480-484
10. Ferguson TB Jr, Ferguson CL, Grites K, Crimmins-Reda P. The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations. J Thorac Cariovasc Surg 1996;111:742-751
11. Sohail MR, Friedman PA, Khan AH, Hayes DL, Wilson WR, Steckelberg JM et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter- defibrillator infection. Mayo Clin Proc 2008;83:46-53
12. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR et al. Management and outcome of permanent pacemaker and implantable cardioverter- defibrillator infections. JACC 2007;49:1851-1859
13. Baddour LM, Bettman MA, Bolger AF, Epstein AE, Ferieri P, Gerber AP et al. AHA scientific statement: non-valvular cardiovascular device-related infections. Circulation 2003;108:2015-2031
14. Chamis AZ, Peterson GE, Cabell CE, Corey R, Serrentino RA, Greenfiled RA et al. Staphylococcus Aureus bacteraemia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001;104:1029-1033
15. Sohail MR, Friedman PA, Baddour LM. Risk factors for electrophysiologic cardiac device infections: a case control study. 43rd Annual Meeting of the Infectious Diseases Society of America: Abstract 343
16. Bloom H, Mera F, Delurgio D, Beshai J, Langberg J, Heeke B et al. Renal insufficiency and the risk of infection from pacemaker or implantable cardioverter-defibrillator surgey. Pacing Clin Electrophysiol 2006;29:142-145
17. Al-Khatib SM, Malenka DJ, Weinnberg DE, Lucas FZ, Jollis JG. The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating medicare beneficiaries. JACC 2005;46:1536-1540
18. Klug D, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL et al. The PEOPLE study: risk factors related to infections of implanted pacemakers and cardioverter- defibrillators-results of a large prospective study. Circulation 2007;116: 1349-1355
19. Sohail MR, Uslan DZ, Khan AH, Freidman PA, Hayes DL, Wilson WR et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007;45:166-173
20. Bracke FA, Meijer A, Van Gelder LM. Pacemaker lead complications: when is extraction appropriate and what can we learn from published data? Heart 2001; 85:254-259
21. Da Costa A, Kirkovian G, Coucherat M, Delahaye F, Chevalier P, Cerisier A et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 1998;97:1796-1801
22. Lakkireddy D, Valasereddi S, Ryschan K, Basarkadn K, Reveng K, Mohuddin S et al. The impact of povidone-iodine pocket irrigation use on pacemaker and defibrillator infections. Pacing Clin Electrophysiol 2005;28:789-794